The combined use of nirsevimab and maternal respiratory syncytial virus vaccine is linked to a lower burden of severe RSV infection among infants aged 7 months or younger in Washington state.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/rsv-prevention-products-tied-fewer-kids-hospital-visits-2026a1000c34?src=rss
Author :
Publish date : 2026-04-17 12:11:00
Copyright for syndicated content belongs to the linked Source.
